SAN DIEGO, Calif. – Paragon BioTeck, Inc., a privately-held pharmaceutical and medical device company, announced today that Captain Ed Woodward, former standout Air Force pilot and Tillman Military Scholar will be inducted as an honorary member of the company’s Scientific Advisory Board (SAB) at ASCRS. Woodward currently attends University of South Florida’s (USF) Morsani School of Medicine; he was medically retired from the Air Force after sustaining a traumatic brain injury (TBI) during inflight training.
PORTLAND, Ore. — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, announced today that it has received CE mark approval for the recently FDA cleared Comfortear® Lacrisolve™ Absorbable Punctum Plug. CE mark approval is recognized and associated with safety and performance in multiple countries.
PORTLAND, Ore. — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic […]
PORTLAND, Ore. — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, […]
PORTLAND, Ore. — Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, […]
PORTLAND, Ore. — Paragon BioTeck, Inc., today announced that it has signed a distribution agreement with Horus Pharma for rights […]
Recent U.S FDA Approval of Paragon’s NDA Clears the Way for Bausch + Lomb Commercialization TIGARD, Ore. & MADISON, N.J. […]
TIGARD, Ore. — Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, […]
TIGARD, Ore. — Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, […]
TIGARD, Ore. — Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, […]